KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Jazz Pharmaceuticals (JAZZ) Return on Invested Capital: 2014-2023

Historic Return on Invested Capital for Jazz Pharmaceuticals (JAZZ) over the last 5 years, with Jun 2023 value amounting to 0.00%.

  • Jazz Pharmaceuticals' Return on Invested Capital fell 1.00% to 0.00% in Q2 2023 from the same period last year, while for Jun 2023 it was 0.00%, marking a year-over-year decrease of 1.00%. This contributed to the annual value of -0.00% for FY2022, which is N/A change from last year.
  • Per Jazz Pharmaceuticals' latest filing, its Return on Invested Capital stood at 0.00% for Q2 2023, which was up 207.95% from -0.00% recorded in Q1 2023.
  • Jazz Pharmaceuticals' Return on Invested Capital's 5-year high stood at 0.13% during Q1 2019, with a 5-year trough of -0.00% in Q4 2022.
  • Over the past 3 years, Jazz Pharmaceuticals' median Return on Invested Capital value was 0.00% (recorded in 2022), while the average stood at 0.02%.
  • As far as peak fluctuations go, Jazz Pharmaceuticals' Return on Invested Capital grew by 1bps in 2022, and later decreased by 1bps in 2023.
  • Jazz Pharmaceuticals' Return on Invested Capital (Quarterly) stood at 0.13% in 2019, then reached 0.06% in 2020, then reached 0.01% in 2021, then increased by 1bps to -0.00% in 2022, then fell by 1bps to 0.00% in 2023.
  • Its Return on Invested Capital stands at 0.00% for Q2 2023, versus -0.00% for Q1 2023 and -0.00% for Q4 2022.